Growth Metrics

ImmunityBio (IBRX) Cash from Investing Activities Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -114.28%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -674.01%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -122.45%
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn -866.53%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -866.53%
Dec 31, 2025 343.09%
Sep 30, 2025 -378.88%
Jun 30, 2025 68.65%
Mar 31, 2025 111.59%
Dec 31, 2024 337.26%
Sep 30, 2024 516.05%
Jun 30, 2024 -498.44%
Mar 31, 2024 -319.87%
Dec 31, 2023 111.90%
Sep 30, 2023 -1,238.27%
Jun 30, 2023 -107.37%
Mar 31, 2023 87.76%
Dec 31, 2022 86.29%
Sep 30, 2022 -111.04%
Jun 30, 2022 1,012.33%
Mar 31, 2022 -317.66%
Dec 31, 2021 -1,926.40%
Sep 30, 2021 118.69%
Jun 30, 2021 -31.33%
Mar 31, 2021 127.56%
Dec 31, 2020 -18.51%
Sep 30, 2020 -425.92%
Jun 30, 2020 34.24%
Mar 31, 2020 171.92%
Dec 31, 2019 -41.82%
Sep 30, 2019 2.96%
Jun 30, 2019 -46.81%
Mar 31, 2019 -766.40%
Dec 31, 2018 -19.36%
Sep 30, 2018 142.41%
Jun 30, 2018 -62.35%
Mar 31, 2018 -81.79%
Dec 31, 2017 333.15%
Sep 30, 2017 1.55%
Jun 30, 2017 659.74%
Mar 31, 2017 115.74%
Dec 31, 2016 95.08%
Sep 30, 2016 1,153.00%
Jun 30, 2016 -1,600.34%
Mar 31, 2016 -5,390.95%
Dec 31, 2015 -573,633.33%
Sep 30, 2015 -246.28%
Jun 30, 2015 -3,042.11%
Mar 31, 2015 -92,900.00%